In-vitro antimicrobial activity of HMR 3004 (RU 64004) against erythromycin A-sensitive and -resistant Corynebacterium spp. isolated from clinical specimens

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 5, 1998, Pages 647-649

  Soriano, Francisco ^a   Fernández Roblas, Ricardo ^a   Calvo, Raquel ^a   García Calvo, Gloria ^a   Pardeiro, Mercedes ^a   Bryskier, André ^b  

^a Department of Medical Microbiology Fund Jiménez Díaz ^*  (Spain)

^b Hoechst Marion Roussel   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN; HMR 3004; JOSAMYCIN; LINCOMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CORYNEBACTERIUM; NONHUMAN;

EID: 0031771694     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.5.647     Document Type: Article

References (10)

1. Bryskier, A., Agouridas, C. & Chantot, J. F. (1997). Ketolides: new semi-synthetic 14-membered ring macrolides. In Expanding Indications for the New Macrolides, Azalides and Streptogramins (Zinner, S. H., Young, L. S., Acar, J. F. & Neu, H. C., Eds), pp. 39-50. Marcel Dekker, New York.
2. Ednie, L. M., Spangler, S. K., Jacobs, M. R. & Appelbaum, P. C. (1997). Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents. Antimicrobial Agents and Chemotherapy 41, 1033-6.
3. Ednie, L. M., Spangler, S. K., Jacobs, M. R. & Appelbaum, P. C. (1997). Antianaerobic activity of the ketolide RU 64004 compared to activities of four macrolides, five β-lactams, clindamycin, and metronidazole. Antimicrobial Agents and Chemotherapy 41, 1037-41.
4. Jamjian, C., Biedenbach, D. J. & Jones, R. N. (1997). In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004. Antimicrobial Agents and Chemotherapy 41, 454-9.
5. Schülin, T., Wennersten, C. B., Moellering, R. C. & Eliopoulos, G. M. (1997). In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria. Antimicrobial Agents and Chemotherapy 41, 1196-202.
6. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fourth Edition: Approved Standard M7-A4. NCCLS, Villanova, PA.
7. Comité de l'Antibiogramme de la Société Française de Microbiologie. (1996). Zone sizes and MIC breakpoints for non-fastidious organisms. 1996 Report of the Comité de l'Antibiogramme de la Société Française de Microbiologie. Clinical Microbiology and Infection 2, Suppl. 1, S46-9.
8. Soriano, F., Zapardiel, J. & Nieto, E. (1995). Antimicrobial susceptibilities of Corynebacterium species and other non-sporeforming gram-positive bacilli to 18 antimicrobial agents. Antimicrobial Agents and Chemotherapy 39, 208-14.
9. Leclercq, R. & Courvalin, P. (1991). Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria. Antimicrobial Agents and Chemotherapy 35, 1273-6.
10. B resistance phenotype. Journal of Antimicrobial Chemotherapy 40, 85-90.